Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Umbilical cord blood transplantation in adult myeloid leukemia

Abstract

Allogeneic hematopoietic stem cell (HSC) transplantation is a life-saving procedure for hematopoietic malignancies, marrow failure syndromes and hereditary immunodeficiency disorders. However, wide application of this procedure is limited by availability of suitable human leucocyte antigen (HLA)-matched adult donors. Umbilical cord blood (UCB) has been increasingly used as an alternative HSC source for patients lacking matched-HSC donors. The clinical experience of using UCB transplantation to treat pediatric acute leukemias has already shown that higher-level HLA-mismatched UCB can be equally as good as or even better than matched HSC. Recently, large registries and multiple single institutional studies conclusively demonstrated that UCB is an acceptable source of HSCs for adult acute leukemia patients who lack HLA-matched donors. These studies will impact the future clinical allogeneic stem cell transplantation for acute myeloid leukemia (AML), which is the most common acute leukemia in adults. UCB has unique advantages of easy procurement, absence of risk to donors, low risk of transmitting infections, immediate availability, greater tolerance of HLA disparity and lower-than-expected incidence of severe graft-versus-host disease. These features of UCB permit successful transplantation available to almost every patient who needs it. We anticipate that using UCB as a HSC source for allogeneic transplantation for adult AML will increase dramatically over the next 5 years, by expanding the available allogeneic donor pool. Clinical studies are needed with focus on disease-specific UCB transplantation outcomes, including AML, acute lymphoblastic leukemia, and lymphoma.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Ende M, Ende N . Hematopoietic transplantation by means of fetal (cord) blood. Virginia Med J 1972; 99: 276–280.

    CAS  Google Scholar 

  2. Broxmeyer HE, Douglas GW, Hangoc G, Cooper S, Bard J, English D et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 1989; 86: 3828–3832.

    Article  CAS  Google Scholar 

  3. Gluckman E, Broxmeyer HA, Auerbach AD, Friedman HS, Douglas GW, Devergie A et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989; 321: 1174–1178.

    Article  CAS  Google Scholar 

  4. Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611–1618.

    CAS  PubMed  Google Scholar 

  5. Locatelli F, Rocha V, Reed W, Bernaudin F, Ertem M, Grafakos S et al., Eurocord Transplant Group. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 2003; 101: 2137–2143.

    Article  CAS  Google Scholar 

  6. Rocha V, Wagner JE, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med 2000; 342: 1846–1854.

    Article  CAS  Google Scholar 

  7. Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, Arcese W, Pasquini R et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997; 337: 373–381.

    Article  CAS  Google Scholar 

  8. Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 1565–1577.

    Article  CAS  Google Scholar 

  9. Kurtzberg J, Laughlin MJ, Graham ML, Smith C, Olson JF, Halperin EC et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996; 335: 157–166.

    Article  CAS  Google Scholar 

  10. Wagner JE, Rosenthal J, Sweetman R, Shu XO, Davies SM, Ramsay NK et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 1996; 88: 795–802.

    CAS  PubMed  Google Scholar 

  11. Laughlin MJ, Barker JN, Bambach B, Koc O, Rizzieri D, Wagner JE et al. Hematopoietic engraftment and survival in adult recipients of umbilical cord blood from unrelated donors. N Engl J Med 2001; 344: 1815–1822.

    Article  CAS  Google Scholar 

  12. Barker JN, Davies SM, DeFor T, Ramsay NK, Weisdorf DJ, Wagner JE . Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 2001; 97: 2957–2961.

    Article  CAS  Google Scholar 

  13. Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004; 351: 2265–2275.

    Article  CAS  Google Scholar 

  14. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A et al., Acute Leukemia Working Party of European Blood and Marrow Transplant Group. Eurocord-netcord registry. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004; 351: 2276–2285.

    Article  CAS  Google Scholar 

  15. Hwang WY, Samuel M, Tan D, Koh LP, Lim W, Linn YC . A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients. Biol Blood Marrow Transplant 2007; 13: 444–453.

    Article  Google Scholar 

  16. Gluckman E, Rocha V . Donor selection for unrelated cord blood transplants. Curr Opin Immunol 2006; 18: 565–570.

    Article  CAS  Google Scholar 

  17. Gluckman E, Rocha V, Arcese W, Michel G, Sanz G, Chan KW et al., Eurocord Group. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 2004; 32: 397–407.

    Article  CAS  Google Scholar 

  18. Hamza NS, Lisgaris M, Yadavalli GK, Fu P, Lazarus HM, Koc ON et al. Infectious complications after unrelated HLA-mismatched allogeneic umbilical cord blood transplantation in adults. Br J Haematol 2004; 124: 488–498.

    Article  Google Scholar 

  19. Ruggeri L, Capanni M, Casucci M, Volpi I, Tosti A, Perruccio K et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 1999; 94: 333–339.

    CAS  PubMed  Google Scholar 

  20. Flomenberg N, Baxter-Lowe LA, Confer D, Fernandez-Vina M, Filipovich A, Horowitz M et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 2004; 104: 1923–1930.

    Article  CAS  Google Scholar 

  21. Mommaas B, Stegehuis-Kamp J, van Halteren AG, Kester M, Enczmann J, Wernet P et al. Cord blood comprises antigen-experienced T cells specific for maternal minor histocompatibility antigen HA-1. Blood 2005; 105: 1823–1827.

    Article  CAS  Google Scholar 

  22. Roy V, Verfaillie CM . Expression and function of cell adhesion molecules on fetal liver, cord blood and bone marrow hematopoietic progenitors: implications for anatomical localization and developmental stage specific regulation of hematopoiesis. Exp Hematol 1999; 27: 302–312.

    Article  CAS  Google Scholar 

  23. Peled A, Kollet O, Ponomaryov T, Petit I, Franitza S, Grabovsky V et al. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood 2000; 95: 3289–3296.

    CAS  PubMed  Google Scholar 

  24. Zheng Y, Watanabe N, Nagamura-Inoue T, Igura K, Nagayama H, Tojo A et al. Ex vivo manipulation of umbilical cord blood-derived hematopoietic stem/progenitor cells with recombinant human stem cell factor can up-regulate levels of homing-essential molecules to increase their transmigratory potential. Exp Hematol 2003; 31: 1237–1246.

    Article  CAS  Google Scholar 

  25. Mazurier F, Doedens M, Gan OI, Dick JE . Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells. Nat Med 2003; 9: 959–963.

    Article  CAS  Google Scholar 

  26. Hiruma K, Nakamura H, Henkart PA, Gress RE . Clonal deletion of postthymic T cell: veto cells kill precursor cytotoxic T lymphocytes. J Exp Med 1992; 175: 863–870.

    Article  CAS  Google Scholar 

  27. Bender JG, Unverzagt K, Walker DE, Lee W, Smith S, Williams S et al. Phenotypic analysis and characterization of CD34+ cells from normal human bone marrow, cord blood, peripheral blood, and mobilized peripheral blood from patients undergoing autologous stem cell transplantation. Clin Immunol Immunopath 1994; 70: 10–18.

    Article  CAS  Google Scholar 

  28. Gomi S HS, Dan K, Wakabayashi I . A comparative analysis of the transplant potential of umbilical cord blood versus mobilized peripheral blood stem cells. Nippon Ika Daigaku Zasshi 1997; 64: 307–313.

    Article  Google Scholar 

  29. Theunissen K, Verfaillie CM . A multifactorial analysis of umbilical cord blood, adult bone marrow and mobilized peripheral blood progenitors using the improved ML-IC assay. Exp Hematol 2005; 33: 165–172.

    Article  CAS  Google Scholar 

  30. Ng YY, van Kessel B, Lokhorst HM, Baert MR, van den Burg CM, Bloem AC et al. Gene-expression profiling of CD34+ cells from various hematopoietic stem-cell sources reveals functional differences in stem-cell activity. J Leukoc Biol 2004; 75: 314–323.

    Article  CAS  Google Scholar 

  31. Chalmers I, Janossy G, Contreras M, Navarrete C . Intracellular cytokine profile of cord and adult blood lymphocytes. Blood 1998; 92: 11–18.

    CAS  PubMed  Google Scholar 

  32. Kadereit S, Deeds LS, Haynesworth SE, Koc ON, Kozik MM, Szekely E et al. Expansion of LTC-ICs and maintenance of p21 and BCL-2 expression in cord blood CD34(+)/CD38(−) early progenitors cultured over human MSCs as a feeder layer. Stem Cells 2002; 20: 573–582.

    Article  CAS  Google Scholar 

  33. Kadereit S, Mohammad SF, Miller RE, Wood KD, Listrom CD, McKinnon K et al. Reduced NFAT1 protein expression in human umbilical cord blood T lymphocytes. Blood 1999; 94: 3101–3107.

    CAS  PubMed  Google Scholar 

  34. Ng WF, Duggan PJ, Ponchel F, Matarese G, Lombardi G, Edwards AD et al. Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. Blood 2001; 98: 2736–2744.

    Article  CAS  Google Scholar 

  35. Godfrey WR, Spoden DJ, Ge YG, Baker SR, Liu B, Levine BL et al. Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood 2005; 105: 750–758.

    Article  CAS  Google Scholar 

  36. Li L, Godfrey WR, Porter SB, Ge YG, June CH, Blazar BR et al. CD4+CD25+ regulatory T cell lines from human cord blood have functional and molecular properties of T cell anergy. Blood 2005; 106: 3068–3073.

    Article  CAS  Google Scholar 

  37. Liu E, Law HK, Lau YL . Tolerance associated with cord blood transplantation may depend on the state of host dendritic cells. Br J Haematol 2004; 126: 517–526.

    Article  Google Scholar 

  38. Brahmi Z, Hommel-Berrey G, Smith F, Thomson B . NK cells recover early and mediate cytotoxicity via perforin/granzyme and Fas/FasL pathways in umbilical cord blood recipients. Hum Immunol 2005; 62: 782–790.

    Article  Google Scholar 

  39. Saavedra S, Sanz GF, Jarque I, Moscardo F, Jimenez C, Lorenzo I et al. Early infections in adult patients undergoing unrelated donor cord blood transplantation. Bone Marrow Transplant 2002; 30: 937–943.

    Article  CAS  Google Scholar 

  40. Tomonari A, Iseki T, Ooi J, Takahashi S, Shindo M, Ishii K et al. Cytomegalovirus infection following unrelated cord blood transplantation for adult patients: a single institute experience in Japan. Br J Haematol 2003; 121: 304–311.

    Article  Google Scholar 

  41. Barker JN, Hough RE, Van Burik JA, Defor TE, Macmillan ML, O’Brien MR et al. Serious infections after unrelated donor transplantation in 136 children: impact of stem cell source. Biol Blood and Marrow Transplant 2005; 11: 362–370.

    Article  Google Scholar 

  42. Barker JN, Martin PL, Coad JE, DeFor T, Trigg ME, Kurtzberg J et al. Low incidence of Epstein–Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients. Biol Blood Marrow Transplant 2001; 7: 395–399.

    Article  CAS  Google Scholar 

  43. Brunstein CG, Weisdorf DJ, DeFor T, Barker JN, Tolar J, van Burik JA et al. Marked increased risk of Epstein–Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. Blood 2006; 108: 2874–2880.

    Article  CAS  Google Scholar 

  44. Reddiconto G, Chiusolo P, Fiorini A, Farina G, Laurenti L, Martini M et al. Assessment of cellular origin and EBV status in a PTLD after double cord blood transplantation. Leukemia 2007; 21: 2552–2554.

    Article  CAS  Google Scholar 

  45. Majhail NS, Brunstein CG, Wagner JE . Double umbilical cord blood transplantation. Curr Opin Immunol 2006; 18: 571–575.

    Article  CAS  Google Scholar 

  46. Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, Miller JS, Wagner JE . Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced intensity conditioning. Blood 2003; 102: 1915–1919.

    Article  CAS  Google Scholar 

  47. Morri T, Amano I, Tanaka H . Reduced-intensity unrelated cord blood transplantation in adult patients with high-risk hematological malignancies. Blood 2005; 106: 444b.

    Article  Google Scholar 

  48. Misawa M, Kai S, Okada M, Nakajima T, Nomura K, Wakae T et al. Reduced-intensity conditioning followed by unrelated umbilical cord blood transplantation for advanced hematologic malignancies: rapid engraftment in bone marrow. Int J Hematol 2006; 83: 74–79.

    Article  CAS  Google Scholar 

  49. Brunstein C, Barker J, DeFor T . Nonmyeloablative umbilical cord blood transplantation: promising disease-free survival in 95 consecutive patients. Blood 2005; 106: 166a.

    Google Scholar 

  50. Rio B, Belhocine R, Renaud M . Reduced intensity conditioning regimen for unrelated cord blood transplantation in adult. A multicentric phase I–II trial. Blood 2005; 106: 1018a.

    Google Scholar 

  51. Miyakoshi S, Yuji K, Kami M, Kusumi E, Kishi Y, Kobayashi K et al. Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases. Clin Cancer Res 2004; 10: 3586–3592.

    Article  Google Scholar 

  52. Ballen K, Spitzer TR, Yeap B . Excellent disease-free survival after double cord blood transplantation using a reduced intensity chemotherapy only conditioning regimen in a diverse adult population. Blood 2005; 106: 579a.

    Google Scholar 

  53. Nauta AJ, Kruisselbrink AB, Lurvink E, Mulder A, Claas FH, Noort WA et al. Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit. Exp Hematol 2005; 33: 1249–1256.

    Article  Google Scholar 

  54. Kim DW, Chung YJ, Kim TG, Kim YL, Oh IH . Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation. Blood 2004; 103: 1941–1948.

    Article  CAS  Google Scholar 

  55. Liu M, Reese JS, Jaroscak JJ, Gerson SL . Progressive emergence of a dominant unit during dual unit umbilical cord blood culture. Blood Suppl, ASH Abstract 2005; 106: 2191a.

    Google Scholar 

  56. Barker JN, Weisdorf DJ, Wagner JE . Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. N Engl J Med 2001; 344: 1870–1871.

    Article  CAS  Google Scholar 

  57. Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, McGlave PB, Miller JS et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005; 105: 1343–1347.

    Article  CAS  Google Scholar 

  58. Brunstein CG, Baker KS, Wagner JE . Umbilical cord blood transplantation for myeloid malignancies. Curr Opin Hematol 2007; 14: 162–169.

    Article  Google Scholar 

  59. Takahashi S, Iseki T, Ooi J, Tomonari A, Takasugi K, Shimohakamada Y et al. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood 2004; 104: 3813–3820.

    Article  CAS  Google Scholar 

  60. Takahashi S, Ooi J, Tomonari A, Konuma T, Tsukada N, Oiwa-Monna M et al. Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen. Blood 2007; 109: 1322–1330.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This UCB Program was supported by the Abraham J. and Phyllis Katz Foundation, Fannie E. Rippel Foundation and Dr Donald and Ruth Weber Goodman Philanthropic Fund.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M J Laughlin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tse, W., Zang, S., Bunting, K. et al. Umbilical cord blood transplantation in adult myeloid leukemia. Bone Marrow Transplant 41, 465–472 (2008). https://doi.org/10.1038/sj.bmt.1705994

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705994

Keywords

This article is cited by

Search

Quick links